{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:32:16Z","timestamp":1789450336016,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cockayne syndrome is a progressive multisystem genetic disorder linked to defective DNA repair and transcription. This rare condition encompasses a very wide spectrum of clinical severity levels ranging from severe prenatal onset to mild adult-onset subtypes. The rarity, complexity and variability of the disease make early diagnosis and severity assessment difficult. Based on similar approaches in other neurodegenerative disorders, we propose to validate diagnostic and severity scores for Cockayne syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinical, imaging and genetic data were retrospectively collected from 69 molecularly confirmed CS patients. A clinical diagnostic score and a clinical-radiological diagnostic score for CS were built using a multivariable logistic regression model with a stepwise variable selection procedure. A severity score for CS was designed on five items (head circumference, growth failure, neurosensorial signs, motor autonomy, communication skills) and validated by comparison with classical predefined severity subtypes of CS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Short stature, enophtalmos, hearing loss, cataracts, cutaneous photosensitivity, frequent dental caries, enamel hypoplasia, morphological abnormalities of the teeth, areflexia and spasticity were included in the clinical diagnostic score as being the most statistically relevant criteria. Appropriate weights and thresholds were assigned to obtain optimal sensitivity and specificity (95.7% and 86.4% respectively). The severity score was shown to be able to quantitatively differentiate classical predefined subtypes of CS and confirmed the continuous distribution of the clinical presentations in CS. Longitudinal follow-up of the severity score was able to reflect the natural course of the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The diagnostic and severity scores for CS will facilitate early diagnosis and longitudinal evaluation of future therapeutic interventions. Prospective studies will be needed to confirm these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01686-8","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T20:02:46Z","timestamp":1612382566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Diagnostic and severity scores for Cockayne syndrome"],"prefix":"10.1186","volume":"16","author":[{"given":"M. A.","family":"Spitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Severac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Obringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Le May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Calmels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5782-6538","authenticated-orcid":false,"given":"V.","family":"Laugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"issue":"61","key":"1686_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/adc.11.61.1","volume":"11","author":"EA Cockayne","year":"1936","unstructured":"Cockayne EA. Dwarfism with retinal atrophy and deafness. Arch Dis Child. 1936;11(61):1\u20138.","journal-title":"Arch Dis Child"},{"issue":"5","key":"1686_CR2","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.dnarep.2008.01.014","volume":"7","author":"WJ Kleijer","year":"2008","unstructured":"Kleijer WJ, Laugel V, Berneburg M, Nardo T, Fawcett H, Gratchev A, et al. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum. Cockayne Syndrome Trichothiodystrophy DNA Repair. 2008;7(5):744\u201350.","journal-title":"Cockayne Syndrome Trichothiodystrophy DNA Repair"},{"issue":"4","key":"1686_CR3","first-page":"1473","volume":"42","author":"LV Mayne","year":"1982","unstructured":"Mayne LV, Lehmann AR. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne\u2019s syndrome and xeroderma pigmentosum. Cancer Res. 1982;42(4):1473\u20138.","journal-title":"Cancer Res"},{"issue":"10","key":"1686_CR4","first-page":"4237","volume":"39","author":"AR Lehmann","year":"1979","unstructured":"Lehmann AR, Kirk-Bell S, Mayne L. Abnormal kinetics of DNA synthesis in ultraviolet light-irradiated cells from patients with Cockayne\u2019s syndrome. Cancer Res. 1979;39(10):4237\u201341.","journal-title":"Cancer Res"},{"issue":"4","key":"1686_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0092-8674(95)90028-4","volume":"82","author":"KA Henning","year":"1995","unstructured":"Henning KA, Li L, Iyer N, McDaniel LD, Reagan MS, Legerski R, et al. The Cockayne syndrome group a gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell. 1995;82(4):555\u201364.","journal-title":"Cell"},{"issue":"6","key":"1686_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/0092-8674(92)90390-X","volume":"71","author":"C Troelstra","year":"1992","unstructured":"Troelstra C, van Gool A, de Wit J, Vermeulen W, Bootsma D, Hoeijmakers JH. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne\u2019s syndrome and preferential repair of active genes. Cell. 1992;71(6):939\u201353.","journal-title":"Cell"},{"issue":"1","key":"1686_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ajmg.1320420115","volume":"42","author":"MA Nance","year":"1992","unstructured":"Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet. 1992;42(1):68\u201384.","journal-title":"Am J Med Genet"},{"issue":"5\u20136","key":"1686_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.mad.2013.02.006","volume":"134","author":"V Laugel","year":"2013","unstructured":"Laugel V. Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev. 2013;134(5\u20136):161\u201370.","journal-title":"Mech Ageing Dev"},{"issue":"5","key":"1686_CR9","first-page":"483","volume":"18","author":"BT Wilson","year":"2016","unstructured":"Wilson BT, Stark Z, Sutton RE, Danda S, Ekbote AV, Elsayed SM, et al. The Cockayne syndrome natural history (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. Genet Med Off J Am Coll Med Genet. 2016;18(5):483\u201393.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"5","key":"1686_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ajmg.a.33933","volume":"155A","author":"V Natale","year":"2011","unstructured":"Natale V. A comprehensive description of the severity groups in Cockayne syndrome. Am J Med Genet A. 2011;155A(5):1081\u201395.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1686_CR11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3174\/ajnr.A2135","volume":"31","author":"M Koob","year":"2010","unstructured":"Koob M, Laugel V, Durand M, Fothergill H, Dalloz C, Sauvanaud F, Dollfus H, Namer IJ, Dietemann JL. Neuroimaging in Cockayne syndrome. AJNR Am J Neuroradiol. 2010;31(9):1623\u201330.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"1686_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1568-7864(02)00056-3","volume":"1","author":"G Spivak","year":"2002","unstructured":"Spivak G, Itoh T, Matsunaga T, Nikaido O, Hanawalt P, Yamaizumi M. Ultraviolet-sensitive syndrome cells are defective in transcription-coupled repair of cyclobutane pyrimidine dimers. DNA Repair (Amst). 2002;1(8):629\u201343.","journal-title":"DNA Repair (Amst)"},{"issue":"10","key":"1686_CR13","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1212\/WNL.55.10.1442","volume":"55","author":"I Rapin","year":"2000","unstructured":"Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH. Cockayne syndrome and xeroderma pigmentosum. Neurology. 2000;55(10):1442\u20139.","journal-title":"Neurology"},{"issue":"9","key":"1686_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/jmg.2007.057141","volume":"45","author":"V Laugel","year":"2008","unstructured":"Laugel V, Dalloz C, Tobias ES, Tolmie JL, Martin-Coignard D, Drouin-Garraud V, Valayannopoulos V, Sarasin A, Dollfus H. Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. J Med Genet. 2008;45(9):564\u201371.","journal-title":"J Med Genet"},{"issue":"20","key":"1686_CR15","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1212\/WNL.0b013e3182563b82","volume":"78","author":"FA Wijburg","year":"2012","unstructured":"Wijburg FA, Sedel F, Pineda M, Hendriksz CJ, Fahey M, Walterfang M, Patterson MC, Wraith JE, Kolb SA. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology. 2012;78(20):1560\u20137.","journal-title":"Neurology"},{"issue":"3","key":"1686_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F. NP-C Guidelines Working Group Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab. 2012;106(3):330\u201344.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1686_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ajmg.10660","volume":"112","author":"R Steinfeld","year":"2002","unstructured":"Steinfeld R, Heim P, von Gregory H, Meyer K, Ullrich K, Goebel HH, Kohlsch\u00fctter A. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet. 2002;112(4):347\u201354.","journal-title":"Am J Med Genet"},{"issue":"2","key":"1686_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/01.wnl.0000169019.41332.8a","volume":"65","author":"FJ Marshall","year":"2005","unstructured":"Marshall FJ, de Blieck EA, Mink JW, Dure L, Adams H, Messing S, Rothberg PG, Levy E, McDonough T, DeYoung J, Wang M, Ramirez-Montealegre D, Kwon JM, Pearce DA. A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology. 2005;65(2):275\u20139.","journal-title":"Neurology"},{"issue":"6","key":"1686_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/01.wnl.0000267885.47092.40","volume":"69","author":"S Worgall","year":"2007","unstructured":"Worgall S, Kekatpure MV, Heier L, Ballon D, Dyke JP, Shungu D, Mao X, Kosofsky B, Kaplitt MG, Souweidane MM, Sondhi D, Hackett NR, Hollmann C, Crystal RG. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis. Neurology. 2007;69(6):521\u201335.","journal-title":"Neurology"},{"key":"1686_CR20","unstructured":"R Project for Statistical Computing: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna. (2020). https:\/\/www.R-project.org\/. Accessed 01 Jun 2020."},{"issue":"20","key":"1686_CR21","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz A, Ajayi T, Specchio N, de Los RE, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlsch\u00fctter A. CLN2 Study Group Study of intraventricular cerliponase alfa for CLN2 disease. N Engl J Med. 2018;378(20):1898\u2013907.","journal-title":"N Engl J Med"},{"issue":"8","key":"1686_CR22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S2352-4642(18)30179-2","volume":"2","author":"M Nickel","year":"2018","unstructured":"Nickel M, Simonati A, Jacoby D, Lezius S, Kilian D, Van de Graaf B, Pagovich OE, Kosofsky B, Yohay K, Downs M, Slasor P, Ajayi T, Crystal RG, Kohlsch\u00fctter A, Sondhi D, Schulz A. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. Lancet Child Adolesc Health. 2018;2(8):582\u201390.","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"1686_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, Iannaccone ST, Kirschner J, Kuntz NL, Saito K, Shieh PB, Tulinius M, Mazzone ES, Montes J, Bishop KM, Yang Q, Foster R, Gheuens S, Bennett CF, Farwell W, Schneider E, De Vivo DC, Finkel RS. CHERISH Study Group Nusinersen versus Sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625\u201335.","journal-title":"N Engl J Med"},{"key":"1686_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10223-9","author":"B De Wel","year":"2020","unstructured":"De Wel B, Goosens V, Sobota A, Van Camp E, Geukens E, Van Kerschaver G, Jagut M, Claes K, Claeys KG. Nusinersen treatment significantly improves hand grip strength, hand motor function and MRC sum scores in adult patients with spinal muscular atrophy types 3 and 4. J Neurol. 2020. https:\/\/doi.org\/10.1007\/s00415-020-10223-9.","journal-title":"J Neurol"},{"issue":"9","key":"1686_CR25","doi-asserted-by":"publisher","first-page":"e0221097","DOI":"10.1371\/journal.pone.0221097","volume":"14","author":"F Muntoni","year":"2019","unstructured":"Muntoni F, Domingos J, Manzur AY, Mayhew A, Guglieri M, Sajeev G, Signorovitch J, Ward SJ. Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy. PLoS ONE. 2019;14(9):e0221097.","journal-title":"PLoS ONE"},{"issue":"9","key":"1686_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.1484","volume":"77","author":"JR Mendell","year":"2020","unstructured":"Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with Duchenne muscular dystrophy: a nonrandomized controlled trial. JAMA Neurol. 2020;77(9):1\u201310.","journal-title":"JAMA Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01686-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-021-01686-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01686-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T20:09:12Z","timestamp":1612382952000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01686-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1686"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01686-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was conducted with the approval of the Ethical Board of Strasbourg University Hospital and the database was declared to relevant French authorities (number DC-2014-2222). All subjects have given their consent for the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects have given their consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}